Creative Capital Management Investments’s RxSight RXST Stock Holding History

Creative Capital Management Investments’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,582	Closed	-$33.6K	–	321
2025 Q2	$33.6K	Hold	2,582	–	–	0.01%	141
2025 Q1	$65.2K	Hold	2,582	–	–	0.03%	94
2024 Q4	$88.8K	Hold	2,582	–	–	0.04%	80
2024 Q3	$128K	Hold	2,582	–	–	0.05%	63
2024 Q2	$155K	Hold	2,582	–	–	0.08%	47
2024 Q1	$133K	Sell	2,582 -638	-20%	-$31.3K	0.07%	52
2023 Q4	$130K	Hold	3,220	–	–	0.08%	50
2023 Q3	$89.8K	Hold	3,220	–	–	0.06%	60
2023 Q2	$92.7K	Hold	3,220	–	–	0.07%	60
2023 Q1	$53.7K	Hold	3,220	–	–	0.04%	95
2022 Q4	$41K	Buy	+3,220	New	+$39.2K	0.04%	81

Other funds holding RXST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Creative Capital Management Investments's RXST Position: Q3 2025 in Review

Creative Capital Management Investments sold out of RxSight (RXST) in Q3 2025, closing a stake of 2,582 shares — an estimated $33.6K sold.

Creative Capital Management Investments first reported a position in RXST in Q4 2022 and held it in 11 quarters. The position peaked at $155K in Q2 2024. 160 funds tracked by Wall St. Rank hold RXST as of Q3 2025.

Creative Capital Management Investments reported no remaining RxSight position as of Q3 2025 after selling out during the quarter.
Creative Capital Management Investments sold 2,582 RxSight shares in Q3 2025, an estimated $33.6K.
Creative Capital Management Investments first reported a position in RxSight in Q4 2022 and held it in 11 quarters.
Creative Capital Management Investments's RxSight position peaked at $155K in Q2 2024.
160 funds tracked by Wall St. Rank held RxSight as of Q3 2025.

Based on Creative Capital Management Investments's 13F filing for Q3 2025, filed 23 Oct 2025.